Novo Nordisk (NVO) Raises 2026 View, but Adjusted Growth Tells a More Complicated Story
Novo Nordisk A/S (NVO) delivered a first-quarter report that looked impressive at first glance. Net sales reached DKK 96,823 million, ...
Friday, August 7, 2026
Tag: Novo
FDA Proposes Curbs on Mass Copycats of Novo, Lilly’s Weight-Loss Drugs
The Food and Drug Administration on April 30 proposed excluding Novo Nordisk and Eli Lilly’s weight-loss drugs from a key ...
Novo Nordisk Failed to Report Deaths of Weight-Loss Drug Patients
The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly ...
Novo Nordisk A/S (NVO) Eyes Solidifying Its Market Position with Increased Advertising Spending
Novo Nordisk A/S (NYSE:NVO) is included in our list of the 13 Best Extremely Profitable Stocks to Invest in Now. ...
Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)’s Weight Loss Pill
We recently published 10 Stocks on Jim Cramer’s Radar. Novo Nordisk A/S (NYSE:NVO) is one of the stocks on Jim Cramer's ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.